Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo

被引:0
|
作者
Takeshi Fukumoto
Susumu Fujiwara
Masanobu Sakaguchi
Masahiro Oka
Naomi Kiyota
Yasuo Ejima
Koichi Nakajima
Chikako Nishigori
机构
[1] Kobe University Graduate School of Medicine,Division of Dermatology, Department of Internal Related
[2] Kobe University Graduate School of Medicine,Division of Medical Oncology/Hematology, Department of Medicine
[3] Kobe University Graduate School of Medicine,Division of Radiation Oncology
[4] Shiso Municipal Hospital,Division of Surgery
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:177 / 178
页数:1
相关论文
共 50 条
  • [1] Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo
    Fukumoto, Takeshi
    Fujiwara, Susumu
    Sakaguchi, Masanobu
    Oka, Masahiro
    Kiyota, Naomi
    Ejima, Yasuo
    Nakajima, Koichi
    Nishigori, Chikako
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (02) : 177 - 178
  • [2] Vitiligo of the Face in a Patient Treated With Vemurafenib for Metastatic Melanoma
    Nasca, Maria Rita
    Lacarrubba, Francesco
    Ferrau, Francesco
    Micali, Giuseppe
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (06) : 766 - 768
  • [3] Long-term Survival in Metastatic Malignant Melanoma: Ipilimumab Followed by Vemurafenib in a Patient with Brain Metastasis
    Balakan, Ozan
    Suner, Ali
    Yigiter, Remzi
    Balakan, Tuba
    Sirikci, Akif
    Sevinc, Alper
    [J]. INTERNAL MEDICINE, 2012, 51 (19) : 2819 - 2823
  • [4] Long-Term Survival in Patients with Metastatic Melanoma Treated with DTIC or Temozolomide
    Kim, Christina
    Lee, Christopher W.
    Kovacic, Laurel
    Shah, Amil
    Klasa, Richard
    Savage, Kerry J.
    [J]. ONCOLOGIST, 2010, 15 (07): : 765 - 771
  • [5] Evaluation of the Long-Term Survival after Treatment with Ipilimumab or Vemurafenib in Patients with Metastatic Malignant Melanoma
    Rudolph, B. M.
    Groffik, A.
    Faidt, D.
    Grabbe, S.
    Loquai, C.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 2 - 3
  • [6] Long-Term Response to Vemurafenib Therapy in Patients with metastatic malignant Melanoma
    Groffik, A.
    Mueller-Brenne, T.
    Rudolph, B.
    Rietz, S.
    Grabbe, S.
    Loquai, C.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 908 - 908
  • [7] Long-term survival of a metastatic cerebral melanoma
    Banayan, A
    Vital, C
    [J]. NEUROCHIRURGIE, 1998, 44 (04) : 275 - 277
  • [8] Long-term control of leptomeningeal disease after radiation therapy and nivolumab in a metastatic melanoma patient
    Wu, Richard C.
    Newman, William
    Patanowitz, Liron
    Branstetter, Barton F.
    Amankulor, Nduka
    Tarhini, Ahmad A.
    [J]. IMMUNOTHERAPY, 2020, 12 (11) : 763 - 769
  • [9] Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report
    Lee, Jee Min
    Mehta, Urvi N.
    Dsouza, Ly H.
    Guadagnolo, Beverly Ashleigh
    Sanders, Deborah L.
    Kim, Kevin B.
    [J]. MELANOMA RESEARCH, 2013, 23 (02) : 175 - 178
  • [10] Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report
    Edmondson, Lindsay A.
    Smith, Leticia V.
    Mallik, Alka
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (08) : 629 - 634